www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/aktien/Encorium-Reports-2008-Second-Quarter-Financial-Results-368499Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced ...http://www.finanzen.net/nachricht/aktien/Encorium-Reports-2008-Second-Quarter-Financial-Results-368499http://www.finanzen.net/nachricht/aktien/Encorium-Group-Schedules-Second-Quarter-Financial-Results-and-Conference-Call-367521Encorium Group, Inc. (Nasdaq: ENCO), a global clinical research organization in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Schedules-Second-Quarter-Financial-Results-and-Conference-Call-367521http://www.finanzen.net/nachricht/aktien/Encorium-Group-Signs-3-5-Million-of-New-Contracts-for-Vaccines-Clinical-Trials-368444Encorium Group, Inc. (Nasdaq: ENCO), a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Signs-3-5-Million-of-New-Contracts-for-Vaccines-Clinical-Trials-368444http://www.finanzen.net/nachricht/aktien/Encorium-Group-Signs-Additional-New-Contracts-Valued-at-5-0-Million-356835Encorium Group, Inc. (Nasdaq: ENCO), a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Signs-Additional-New-Contracts-Valued-at-5-0-Million-356835http://www.finanzen.net/nachricht/aktien/Encorium-Group-Announces-5-1-Million-New-Business-Contract-For-A-Multinational-Cardiovascular-Trial-Of-An-Innovative-Anti-thrombotic-Agent-355101Encorium Group, Inc. (Nasdaq: ENCO) today announced the signing of a contract for $5.1 million with an innovative biotechnology company for a Phase 2 clinical trial to be conducted by Encorium in conjunction with our South American ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Announces-5-1-Million-New-Business-Contract-For-A-Multinational-Cardiovascular-Trial-Of-An-Innovative-Anti-thrombotic-Agent-355101http://www.finanzen.net/nachricht/aktien/Encorium-Group-Inc-Announces-Signing-of-Letter-of-Intent-to-Acquire-Prologue-Research-International-Inc-340488Encorium Group, Inc. (Nasdaq: ENCO) ("Encorium” or "the Company”), a full-service, multinational CRO that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Inc-Announces-Signing-of-Letter-of-Intent-to-Acquire-Prologue-Research-International-Inc-340488http://www.finanzen.net/nachricht/aktien/Encorium-Group-Inc-Announces-Signing-of-Letter-of-Intent-to-Combine-with-Linkcon-Expected-Expansion-Will-Create-Global-CRO-340487Encorium Group, Inc. (Nasdaq: ENCO) ("Encorium” or "the Company”), a full-service multinational CRO that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Inc-Announces-Signing-of-Letter-of-Intent-to-Combine-with-Linkcon-Expected-Expansion-Will-Create-Global-CRO-340487http://www.finanzen.net/nachricht/aktien/Encorium-Group-Inc-Announces-3-2-Million-of-New-Business-Contracts-for-Europe-and-North-America-331992Encorium Group, Inc. (Nasdaq: ENCO), a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Inc-Announces-3-2-Million-of-New-Business-Contracts-for-Europe-and-North-America-331992http://www.finanzen.net/nachricht/aktien/Encorium-Reports-2008-First-Quarter-Financial-Results-328297Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced ...http://www.finanzen.net/nachricht/aktien/Encorium-Reports-2008-First-Quarter-Financial-Results-328297http://www.finanzen.net/nachricht/aktien/Encorium-Group-Appoints-Philip-L-Calamia-Interim-Chief-Financial-Officer-327248Encorium Group, Inc. (Nasdaq: ENCO), a global clinical research organization in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, ...http://www.finanzen.net/nachricht/aktien/Encorium-Group-Appoints-Philip-L-Calamia-Interim-Chief-Financial-Officer-327248